-
1
-
-
34347338692
-
Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire
-
Eholie SP, Tanon A, Polneau S, et al. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2007;45:355-358.
-
(2007)
J Acquir Immune Defic Syndr
, vol.45
, pp. 355-358
-
-
Eholie, S.P.1
Tanon, A.2
Polneau, S.3
-
2
-
-
0036405207
-
Is average adherence to HIV antiretroviral therapy enough?
-
Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17:812-813.
-
(2002)
J Gen Intern Med
, vol.17
, pp. 812-813
-
-
Bangsberg, D.R.1
Deeks, S.G.2
-
3
-
-
33645601918
-
Anti-retroviral adherence in a resource poor setting [abstract]
-
Presented at:, Bangkok
-
Akam A. Anti-retroviral adherence in a resource poor setting [abstract]. Presented at: International AIDS Conference; 2004; Bangkok.
-
(2004)
International AIDS Conference
-
-
Akam, A.1
-
4
-
-
34248577886
-
Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa
-
Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665.
-
(2007)
AIDS Care
, vol.19
, pp. 658-665
-
-
Hardon, A.P.1
Akurut, D.2
Comoro, C.3
-
5
-
-
13244263044
-
Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy
-
Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, et al. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41.
-
(2005)
Int J STD AIDS
, vol.16
, pp. 38-41
-
-
Byakika-Tusiime, J.1
Oyugi, J.H.2
Tumwikirize, W.A.3
-
6
-
-
0242496506
-
Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana
-
Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281-288.
-
(2003)
J Acquir Immune Defic Syndr
, vol.34
, pp. 281-288
-
-
Weiser, S.1
Wolfe, W.2
Bangsberg, D.3
-
7
-
-
34247571878
-
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
-
Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21:965-971.
-
(2007)
AIDS
, vol.21
, pp. 965-971
-
-
Oyugi, J.H.1
Byakika-Tusiime, J.2
Ragland, K.3
-
8
-
-
2342589337
-
Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy
-
Parienti J, Massari V, Descamps D, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004;38:1311-1316.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 1311-1316
-
-
Parienti, J.1
Massari, V.2
Descamps, D.3
|